Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma

被引：0
|
作者：
M Ladetto
S Ferrero
D Drandi
M Festuccia
F Patriarca
N Mordini
S Cena
R Benedetto
G Guarona
F Ferrando
L Brunello
P Ghione
V Boccasavia
R Fanin
P Omedè
L Giaccone
A Palumbo
R Passera
M Boccadoro
B Bruno
机构：
[1] A.O.U. Città della Salute e della Scienza di Torino,Division of Hematology
[2] University of Torino,Department of Molecular Biotechnology and Health Sciences
[3] University of Torino,Division of Hematology
[4] Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo,Division of Hematology
[5] A.O.U,Division of Nuclear Medicine
[6] Udine,undefined
[7] DISM,undefined
[8] University of Udine,undefined
[9] Ospedale ‘S.Croce e Carle’,undefined
[10] Statistical Consultant,undefined
[11] A.O.U. Città della Salute e della Scienza di Torino,undefined
来源：
Leukemia | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1211 / 1214
页数：3
相关论文
共 50 条
  • [1] Prospective Molecular Monitoring of Minimal Residual Disease after Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma
    Bruno, Benedetto
    Ferrero, Simone
    Drandi, Daniela
    Festuccia, Moreno
    Patriarca, Francesca
    Mordini, Nicola
    Cena, Silvia
    Barbero, Daniela
    Monitillo, Luigia
    Ferrando, Federica
    Brunello, Lucia
    Fanin, Renato
    Ghione, Paola
    Omede, Paola
    Giaccone, Luisa
    Palumbo, Antonio
    Passera, Roberto
    Boccadoro, Mario
    Ladetto, Marco
    BLOOD, 2014, 124 (21)
  • [2] Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma
    Ladetto, M.
    Ferrero, S.
    Drandi, D.
    Festuccia, M.
    Patriarca, F.
    Mordini, N.
    Cena, S.
    Benedetto, R.
    Guarona, G.
    Ferrando, F.
    Brunello, L.
    Ghione, P.
    Boccasavia, V.
    Fanin, R.
    Omede, P.
    Giaccone, L.
    Palumbo, A.
    Passera, R.
    Boccadoro, M.
    Bruno, B.
    LEUKEMIA, 2016, 30 (05) : 1211 - 1214
  • [3] Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma
    Bruno, B
    Ladetto, M
    Mordini, N
    Astolfi, M
    Rotta, M
    Cimolin, L
    Compagno, M
    Veneziano, L
    Aitoro, G
    Gallamini, A
    Storb, R
    Boccadoro, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S123 - S124
  • [4] Molecular monitoring of chimerism and minimal residual disease in multiple myeloma patients after non-myeloablative stem cell transplantation
    Galimberti, S
    Benedetti, E
    Fazzi, R
    Papineschi, F
    Caracciolo, F
    Orciuolo, E
    Andreazzoli, F
    Morabito, F
    Cuzzola, M
    Martino, M
    Iacopino, P
    Petrini, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S112 - S112
  • [5] High rates of prolonged molecular remissions after tandem autologous non-myeloablative allografting in newly diagnosed myeloma
    Bruno, B.
    Ferrero, S.
    Drandi, D.
    Festuccia, M.
    Patriarca, F.
    Mordini, N.
    Cena, S.
    Barbero, D.
    Monitillo, L.
    Giaccone, L.
    Barbiero, S.
    Gallamini, A.
    Fanin, R.
    Passera, R.
    Palumbo, A.
    Boccadoro, M.
    Omede, P.
    Ladetto, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S200 - S201
  • [6] Low-dose TBI-based non-myeloablative allografting in newly diagnosed multiple myeloma
    Bruno, B
    Patriarca, F
    Rotta, M
    Maloney, D
    Mordini, N
    Casini, M
    Rambaldi, A
    Carnevale-Schianca, F
    Allione, B
    Soligo, D
    Bavaro, P
    De Fabritiis, P
    Giaccone, L
    Aitoro, G
    Corradini, P
    Busca, A
    Fanin, R
    Gallamini, A
    Coser, P
    Levis, A
    Aglietta, M
    Pogliani, E
    Falda, M
    Massaia, M
    Palumbo, A
    Sandmaier, B
    Storb, R
    Boccadoro, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S9 - S10
  • [7] Qualitative and quantitative molecular follow up of minimal residual disease after non myeloablative allografting for multiple myeloma.
    Bruno, B
    Ladetto, M
    Astolfi, M
    Veneziano, L
    Cimolin, L
    Galletto, E
    Pagliano, G
    Rotta, M
    Mordini, N
    Giaccone, L
    Omedè, P
    Battaglio, S
    Storb, R
    Boccadoro, M
    BLOOD, 2004, 104 (11) : 366B - 366B
  • [8] Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
    Galimberti, S
    Benedetti, E
    Morabito, F
    Papineschi, F
    Callea, V
    Fazzi, R
    Stelitano, C
    Andreazzoli, F
    Guerrini, F
    Ciabatti, E
    Martino, M
    Nobile, F
    Iacopino, P
    Petrini, M
    LEUKEMIA RESEARCH, 2005, 29 (08) : 961 - 966
  • [9] Long-Term Follow up of a Comparison of Non-Myeloablative Allografting with Autografting for Newly Diagnosed Myeloma
    Bruno, Benedetto
    Storer, Barry
    Patriarca, Francesca
    Rotta, Marcello
    Sorasio, Roberto
    Allione, Bernardino
    Carnevale-Schianca, Fabrizio
    Giaccone, Luisa
    Festuccia, Moreno
    Brunello, Lucia
    Omede, Paola
    Ferrando, Federica
    Bringlien, Sara
    Aglietta, Massimo
    Levis, Alessandro
    Mordini, Nicola
    Gallamini, Andrea
    Palumbo, Antonio
    Fanin, Renato
    Storb, Rainer
    Gooley, Ted
    Boccadoro, Mario
    BLOOD, 2010, 116 (21) : 233 - 233
  • [10] Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma
    Yang, Peiyu
    Xu, Weiling
    Liang, Xinyue
    Yu, Shanshan
    Yi, Xingcheng
    Liu, Mengmeng
    Tian, Mengru
    Yue, Tingting
    Zhang, Yingjie
    Yan, Yurong
    Hu, Zhongli
    Guo, Qiang
    Zhang, Nan
    Wang, Jingxuan
    Sun, Xiaoxiao
    Hu, Rui
    Kumar, Shaji K.
    Dai, Yun
    Jin, Fengyan
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (03) : E61 - E64
12345